AMR One Health Network
The AMR One Health Network was held on 24-25 November 2025 between Merber States, EU Agencies and the Commission. Read the news announcement published by DG Health and Food Safety on 3 December 2025.
The AMR One Health Network was held on 24-25 November 2025 between Merber States, EU Agencies and the Commission. Read the news announcement published by DG Health and Food Safety on 3 December 2025.
On behalf of the European Commission, HaDEA has signed a contract with a consortium of European companies to develop a groundbreaking diagnostic device that will provide antimicrobial susceptibility results on bacteria within an hour. This new...
EMA’s Emergency Task Force (ETF) is improving its approach to scientific advice for the most promising medicines and vaccines under development for public health threats. Under the new process, developers of medicines falling within the...
The meeting, hosted by DG SANTE, is aimed to strengthen dialogue between the Task Force and Commission services, fostering a regular exchange on priorities related to One Health. Participants discussed progress on implementing the Cross-agency...
The AMR One Health Network (Member States only) meeting was held on 4 April 2025. Read the news and the presentations published by Directorate-General for Health and Food Safety on 28 April 2025.
The AMR, One Health, Health policy, European Commission meeting was held on 3 April 2025. Read the news and the presentations published by Directorate-General for Health and Food Safety on 28 April 2025.
The European Health and Digital Executive Agency (HaDEA) and the Health Emergency Preparedness and Response (HERA) have prepared video guidelines for the EU4Health call for tenders to develop point-of-care diagnostic medical devices for antimicrobial susceptibility...
This call for tenders aims to speed up the development of a point-of-care diagnostic medical device that can provide antimicrobial susceptibility testing (AST) results on the bacteria or fungi causing an infection in humans, within...
HERA has today signed the second agreement under HERA Invest, its pioneering financial mechanism designed to support the research and development of medical countermeasures (MCMs) and technologies to address priority cross-border health threats. Read the news...
Eight new networks, combining different research specialisms, will work together to tackle one of humanity’s biggest threats, antimicrobial resistance (AMR). The new networks will support diverse teams of AMR researchers, ranging from specialists in agriculture,...